BiotechTube

Lamotrigine Tablets 25 mg + Lamotrigine

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fed

Conditions

Fed

Trial Timeline

Mar 1, 2012 → May 1, 2012

NCT ID
NCT01618825

About Lamotrigine Tablets 25 mg + Lamotrigine

Lamotrigine Tablets 25 mg + Lamotrigine is a phase 1 stage product being developed by Ipca Laboratories for Fed. The current trial status is completed. This product is registered under clinical trial identifier NCT01618825. Target conditions include Fed.

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01618825Phase 1Completed
NCT01618799Phase 1Completed

Competing Products

20 competing products in Fed

See all competitors
ProductCompanyStageHype Score
Pantoprazole SodiumDr. Reddy's LaboratoriesPhase 1
26
DesloratadineDr. Reddy's LaboratoriesPhase 1
26
ReminylDr. Reddy's LaboratoriesPhase 1
26
OlanzapineDr. Reddy's LaboratoriesPhase 1
26
CIPRO®XRDr. Reddy's LaboratoriesPhase 1
26
Olanzapine OD Tablets 5 mgDr. Reddy's LaboratoriesPhase 1
26
Amlodipine Besylate/Benazepril HClDr. Reddy's LaboratoriesPhase 1
26
Mycophenolate MofetilDr. Reddy's LaboratoriesPhase 1
26
Levocetirizine Dihydrochloride tablets 5 mg + Levocetirizine DihydrochlorideIpca LaboratoriesPhase 1
29
Indomethacin Extended-Release Capsules USP 75 mg + Indomethacin Extended Release Capsules USP 75 mgIpca LaboratoriesPhase 1
29
Ondansetron Tablets USP 8 mg + Ondansetron HydrochlorideIpca LaboratoriesPhase 1
29
Risperidone Tablet 1 mg + RisperidoneIpca LaboratoriesPhase 1
29
Metoprolol Succinate ER Tablet 200 mg + 'TOPROL-XL®' ER Tablets 200 mgIpca LaboratoriesPhase 1
29
Bisoprolol Fumarate Tablet 10 mg + BisoprololIpca LaboratoriesPhase 1
29
Lisinopril Tablets 40 mg + LisinoprilIpca LaboratoriesPhase 1
29
Quetiapine Fumarate Tablets 25 mg + Quetiapine FumarateIpca LaboratoriesPhase 1
29
Etodolac Tablets USP 500mg + Etodolac Tablets USP 500 mgIpca LaboratoriesPhase 1
29
Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide TabletsIpca LaboratoriesPhase 1
29
Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 5/500 mg + Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mgAstraZenecaPhase 1
29
DexmethylphenidateCingulatePhase 1
19